Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-09 Purchase | 2022-11-14 4:30 pm | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner | 12,506,250 | $0 | $0 | 62,965,513 (Indirect) | View |
| 2022-07-05 Sale | 2022-07-05 6:48 pm | BIORA THERAPEUTICS INC. | BIOR | Sarna Surbhi Director | 7,517 | $0.61 | $4,585 | 148,774 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-15 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 325,000 | $0 | 603,662 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-15 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 230,000 | $0 | 492,193 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-15 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 819,000 | $0 | 1,539,492 (Direct) | View |
| 2023-12-18 Disposition | 2023-12-20 4:29 pm | 2021-01-06 2025-12-01 | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC Director 10% Owner | 53,500,000 | $0 | 31,460,608 (Indirect) | View |
| 2023-12-18 Option Award | 2023-12-20 4:29 pm | 2023-12-19 2028-12-19 | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC Director 10% Owner | 24,507,608 | $0 | 31,460,608 (Indirect) | View |
| 2023-09-18 Disposition | 2023-09-19 4:15 pm | 2021-01-06 2025-12-01 | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC Director 10% Owner | 50,000,000 | $0 | 88,463,496 (Indirect) | View |
| 2023-09-18 Option Award | 2023-09-19 4:15 pm | 2023-09-18 N/A | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC Director 10% Owner | 33,269,014 | $0 | 88,463,496 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:27 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 210,175 | $0 | 262,193 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 4:27 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 36,183 | $3.14 | 262,193 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:22 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 219,650 | $0 | 278,662 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 4:22 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 40,022 | $3.14 | 278,662 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:21 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 559,450 | $0 | 720,492 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 4:21 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 117,881 | $3.14 | 720,492 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-14 | BIORA THERAPEUTICS INC. | BIOR | Kotzin Brian L. Director | 12,500 | $0 | 30,746 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-14 | BIORA THERAPEUTICS INC. | BIOR | Powell Lynne Director | 12,500 | $0 | 30,746 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:05 pm | N/A 2033-06-14 | BIORA THERAPEUTICS INC. | BIOR | Alter Jeffrey D. Director | 12,500 | $0 | 31,546 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:05 pm | N/A 2033-06-14 | BIORA THERAPEUTICS INC. | BIOR | Howe Jill Ann Director | 12,500 | $0 | 31,916 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 4:56 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 2,807 | $3.35 | 99,034 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 4:55 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 2,368 | $3.35 | 88,201 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 4:54 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 11,249 | $3.35 | 278,923 (Direct) | View |
| 2023-03-15 Tax Withholding | 2023-03-17 9:21 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 10,683 | $2.56 | 90,569 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 9:21 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 79,634 | $0 | 90,569 (Direct) | View |
| 2023-03-15 Tax Withholding | 2023-03-17 9:18 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 22,252 | $2.56 | 290,172 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 9:18 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 200,429 | $0 | 290,172 (Direct) | View |
| 2023-03-15 Tax Withholding | 2023-03-17 9:16 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 11,216 | $2.56 | 101,841 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 9:16 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 84,917 | $0 | 101,841 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 4:15 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 84 | $3.46 | 21,618 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 4:15 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 269 | $3.46 | 28,140 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:55 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner | 42,362 | $0 | 0 (Indirect) | View |
| 2023-01-03 Disposition | 2023-01-05 4:06 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Kotzin Brian L. Director | 44 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:06 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 178 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 44 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Powell Lynne Director | 45 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Alter Jeffrey D. Director | 65 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Sarna Surbhi Director | 8 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 95 | $0 | 0 (Direct) | View |
| 2023-01-03 Disposition | 2023-01-05 4:05 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | Howe Jill Ann Director | 19 | $0 | 0 (Direct) | View |
| 2022-11-15 Tax Withholding | 2022-11-16 9:49 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 4,529 | $0.27 | 542,398 (Direct) | View |
| 2022-11-15 Tax Withholding | 2022-11-16 9:48 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer | 175,071 | $0.27 | 2,799,858 (Direct) | View |
| 2022-11-15 Tax Withholding | 2022-11-16 9:48 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 5,194 | $0.27 | 710,122 (Direct) | View |
| 2022-11-09 Disposition | 2022-11-14 4:30 pm | 2021-06-14 2026-06-14 | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner | 8,097,166 | $0 | 62,965,513 (Indirect) | View |
| 2022-11-09 Option Award | 2022-11-14 4:30 pm | 2023-05-09 2028-05-09 | BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner | 8,097,166 | $0 | 62,965,513 (Indirect) | View |
| 2022-08-15 Tax Withholding | 2022-08-16 6:02 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks | 1,355 | $1.04 | 546,927 (Direct) | View |
| 2022-08-15 Tax Withholding | 2022-08-16 5:58 pm | N/A N/A | BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer | 5,952 | $1.04 | 708,429 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:31 pm | N/A 2032-06-15 | BIORA THERAPEUTICS INC. | BIOR | Kotzin Brian L. Director | 244,964 | $0 | 292,482 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:31 pm | N/A 2032-06-15 | BIORA THERAPEUTICS INC. | BIOR | Howe Jill Ann Director | 244,964 | $0 | 321,718 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:30 pm | N/A 2032-06-15 | BIORA THERAPEUTICS INC. | BIOR | Alter Jeffrey D. Director | 244,964 | $0 | 312,482 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:30 pm | N/A 2032-06-15 | BIORA THERAPEUTICS INC. | BIOR | Powell Lynne Director | 244,964 | $0 | 292,482 (Direct) | View |